Biotechnology Stock News
Categories
- All
- Editor's Picks
- Stock Market News
- Q&A with Gurus
- Gurus' Stock Picks
- Insider Transaction
- Earning Reports
- CEO Shareholder Letters
- Press Release
- Earnings Call Transcripts
- Podcast
Industries
- Aerospace & Defense
- Agriculture
- Asset Management
- Banks
- Beverages - Alcoholic
- Beverages - Non-Alcoholic
- Biotechnology
- Building Materials
- Business Services
- Capital Markets
- Chemicals
- Conglomerates
- Construction
- Consumer Packaged Goods
- Credit Services
- Diversified Financial Services
- Drug Manufacturers
- Education
- Farm & Heavy Construction Machinery
- Forest Products
- Furnishings, Fixtures & Appliances
- Hardware
- Healthcare Plans
- Healthcare Providers & Services
- Homebuilding & Construction
- Industrial Distribution
- Industrial Products
- Insurance
- Interactive Media
- Manufacturing - Apparel & Accessories
- Media - Diversified
- Medical Devices & Instruments
- Medical Diagnostics & Research
- Medical Distribution
- Metals & Mining
- Oil & Gas
- Other Energy Sources
- Packaging & Containers
- Personal Services
- Real Estate
- REITs
- Restaurants
- Retail - Cyclical
- Retail - Defensive
- Semiconductors
- Software
- Steel
- Telecommunication Services
- Tobacco Products
- Transportation
- Travel & Leisure
- Utilities - Independent Power Producers
- Utilities - Regulated
- Vehicles & Parts
- Waste Management
GuruFocus Research Biotechnology
Adaptive Biotechnologies Corp (ADPT) Q1 2024 Earnings Call Transcript Highlights: Strategic Growth and Operational Efficiency
Explore key financial outcomes, strategic initiatives, and expert insights from Adaptive Biotechnologies' first quarter earnings call. May 08, 2024
GuruFocus Research Biotechnology
Ligand Pharmaceuticals Inc (LGND) Q1 2024 Earnings Call Transcript Highlights: Strategic Growth and Robust Financial Performance
Discover how Ligand Pharmaceuticals Inc (LGND) kicked off 2024 with strong financial results and strategic expansions, setting a positive tone for the year ahead. May 08, 2024
GuruFocus Research Biotechnology
Ionis Pharmaceuticals Inc (IONS) Q1 2024 Earnings Call Transcript Highlights: Key Developments and Financial Insights
Explore the pivotal updates from Ionis Pharmaceuticals, including new drug launches, robust pipeline progress, and strategic financial positioning in Q1 2024. May 08, 2024
GuruFocus Research Biotechnology
Apellis Pharmaceuticals Inc (APLS) Q1 2024 Earnings Call Transcript Highlights: Robust Revenue Growth and Strategic Insights
Discover how Apellis Pharmaceuticals Inc navigated Q1 2024 with significant revenue increases and strategic advancements despite competitive challenges. May 08, 2024
GuruFocus Research Biotechnology
Heron Therapeutics Inc (HRTX) Q1 2024 Earnings Call Transcript Highlights: Significant Financial Turnaround and Strategic Insights
Explore how Heron Therapeutics Inc (HRTX) achieved a remarkable improvement in Q1 2024, with detailed projections and strategic developments shaping its future. May 08, 2024
GuruFocus Research Biotechnology
Madrigal Pharmaceuticals Inc (MDGL) (Q1 2024) Earnings Call Transcript Highlights: Navigating Early Challenges and Strategic Wins
Insights into MDGL's financial health, strategic milestones, and initial hurdles in the commercial launch of its NASH treatment. May 08, 2024